Lynn Seely - President and CEO, Director at Lyell Immunopharma, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- President and CEO, Director
- Issuer Symbol
- LYEL on Nasdaq
- All Insider Reports
- All Insider Reports
Lynn Seely - trading volume in the past year for Lyell Immunopharma, Inc.
| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | ||||
| Sells | -16,359 | 100% | $16.87 | -$275,967 |
| Net | -16,359 | -100% | -$275,967 |
Holdings reported by Lynn Seely for Lyell Immunopharma, Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 74,266 | $1,737,081 | $23.39 | 11 Feb 2026 | Direct | ||
| Option (right to buy) | 155,000 | 10 Feb 2026 | Direct | Common Stock |
Transactions reported by Lynn Seely for Lyell Immunopharma, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.